Intuitive Surgical Inc
ISRG483.120USD
+2.030+0.42%
Close 08/01, 16:00（ET）Quotes delayed by 15 min
173.15BMarket Cap
69.93P/E TTM
More Details of Intuitive Surgical Inc Company
Intuitive Surgical, Inc. develops, manufactures, and markets da Vinci surgical systems and the Ion endoluminal system. The Company specializes in invasive care and robotic-assisted surgery. Its technologies include the da Vinci surgical systems and the Ion endoluminal system. The da Vinci surgical system is designed to enable surgeons to perform a range of surgical procedures within its targeted general surgery, urologic, gynecologic, cardiothoracic, and head and neck specialties and consists of a surgeon's console or consoles, a patient-side cart, and a high-performance vision system. The Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform for which the cleared indication is minimally invasive biopsies in the lung and consists of a system cart, a controller, a catheter, and a vision probe. Its Ion system extends its commercial offering beyond surgery into diagnostic and endoluminal procedures.
Company Info
Ticker SymbolISRG
Company nameIntuitive Surgical Inc
IPO dateJun 13, 2000
Founded at1995
CEOMr. David J. Rosa
Number of employees15638
Security typeOrdinary Share
Fiscal year-endJun 13
Address1020 Kifer Road
CitySUNNYVALE
Stock exchangeNASDAQ Global Select Consolidated
CountryUnited States of America
Postal code94086
Phone14085232100
Websitehttps://www.intuitive.com/en-us/about-us/company
Ticker SymbolISRG
IPO dateJun 13, 2000
Founded at1995
Company Executives
Name
Name/Position
Position
Shareholding
Change
Dr. Gary S. Guthart, Ph.D.
Dr. Gary S. Guthart, Ph.D.
Executive Chairman of the Board
Executive Chairman of the Board
1.27M
--
Mr. David J. Rosa
Mr. David J. Rosa
Chief Executive Officer, Director
Chief Executive Officer, Director
231.70K
-0.07%
Dr. Craig H. Barratt, Ph.D.
Dr. Craig H. Barratt, Ph.D.
Lead Independent Director
Lead Independent Director
26.16K
+3.17%
Ms. Amal M. Johnson
Ms. Amal M. Johnson
Independent Director
Independent Director
13.01K
+6.02%
Mr. Henry L. Charlton
Mr. Henry L. Charlton
Executive Vice President, Chief Commercial and Marketing Officer
Executive Vice President, Chief Commercial and Marketing Officer
7.73K
+157.65%
Mr. Joseph C. Beery
Mr. Joseph C. Beery
Independent Director
Independent Director
3.11K
+31.17%
Dr. Monica P. Reed, M.D.
Dr. Monica P. Reed, M.D.
Independent Director
Independent Director
2.35K
+46.01%
Dr. Amy L. Ladd, M.D.
Dr. Amy L. Ladd, M.D.
Independent Director
Independent Director
1.41K
+110.13%
Ms. Sreelakshmi Kolli
Ms. Sreelakshmi Kolli
Independent Director
Independent Director
979.00
+307.92%
Mr. Mark Preston Brosius
Mr. Mark Preston Brosius
Senior Vice President, Chief Manufacturing and Supply Chain Officer
Senior Vice President, Chief Manufacturing and Supply Chain Officer
852.00
-55.81%
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Gary S. Guthart, Ph.D.
Dr. Gary S. Guthart, Ph.D.
Executive Chairman of the Board
Executive Chairman of the Board
1.27M
--
Mr. David J. Rosa
Mr. David J. Rosa
Chief Executive Officer, Director
Chief Executive Officer, Director
231.70K
-0.07%
Dr. Craig H. Barratt, Ph.D.
Dr. Craig H. Barratt, Ph.D.
Lead Independent Director
Lead Independent Director
26.16K
+3.17%
Ms. Amal M. Johnson
Ms. Amal M. Johnson
Independent Director
Independent Director
13.01K
+6.02%
Mr. Henry L. Charlton
Mr. Henry L. Charlton
Executive Vice President, Chief Commercial and Marketing Officer
Executive Vice President, Chief Commercial and Marketing Officer
7.73K
+157.65%
Mr. Joseph C. Beery
Mr. Joseph C. Beery
Independent Director
Independent Director
3.11K
+31.17%
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
FY2018
By BusinessUSD
Name
Revenue
Proportion
Instruments and accessories
1.37B
60.69%
Systems
522.70M
23.20%
Services
363.00M
16.11%
By RegionUSD
Name
Revenue
Proportion
U.S.
1.54B
68.26%
Outside of United states
715.20M
31.74%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Instruments and accessories
1.37B
60.69%
Systems
522.70M
23.20%
Services
363.00M
16.11%
Shareholding Stats
Updated: Thu, May 15
Updated: Thu, May 15
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
9.07%
BlackRock Institutional Trust Company, N.A.
5.28%
State Street Global Advisors (US)
4.29%
T. Rowe Price Associates, Inc.
3.70%
Fidelity Management & Research Company LLC
2.63%
Other
75.03%
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
9.07%
BlackRock Institutional Trust Company, N.A.
5.28%
State Street Global Advisors (US)
4.29%
T. Rowe Price Associates, Inc.
3.70%
Fidelity Management & Research Company LLC
2.63%
Other
75.03%
Shareholder Types
Shareholders
Proportion
Investment Advisor
51.46%
Investment Advisor/Hedge Fund
26.39%
Bank and Trust
2.46%
Research Firm
2.45%
Pension Fund
2.28%
Hedge Fund
2.16%
Sovereign Wealth Fund
1.40%
Individual Investor
0.50%
Family Office
0.16%
Other
10.74%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
3610
320.57M
89.42%
-5.37M
2025Q1
3598
321.67M
89.74%
-4.21M
2024Q4
3426
322.11M
90.31%
-1.17M
2024Q3
3255
319.27M
89.84%
-8.25M
2024Q2
3152
322.86M
91.02%
+572.17K
2024Q1
3116
317.58M
89.60%
-829.16K
2023Q4
3055
314.33M
89.27%
-2.70M
2023Q3
2961
312.82M
89.02%
-3.61M
2023Q2
2932
311.78M
88.97%
-2.17M
2023Q1
2848
309.16M
88.25%
-6.75M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
The Vanguard Group, Inc.
32.51M
9.07%
+452.59K
+1.41%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
18.92M
5.28%
+355.44K
+1.91%
Mar 31, 2025
State Street Global Advisors (US)
15.37M
4.29%
+63.91K
+0.42%
Mar 31, 2025
T. Rowe Price Associates, Inc.
13.26M
3.7%
-697.38K
-5.00%
Mar 31, 2025
Fidelity Management & Research Company LLC
9.44M
2.63%
-1.06M
-10.09%
Mar 31, 2025
Geode Capital Management, L.L.C.
8.08M
2.25%
+322.05K
+4.15%
Mar 31, 2025
Capital World Investors
7.52M
2.1%
+92.44K
+1.24%
Mar 31, 2025
Invesco Capital Management (QQQ Trust)
7.41M
2.07%
+7.47K
+0.10%
Jun 30, 2025
JP Morgan Asset Management
5.55M
1.55%
-1.66M
-23.06%
Mar 31, 2025
Norges Bank Investment Management (NBIM)
4.60M
1.28%
+186.51K
+4.23%
Dec 31, 2024
View more
Related ETFs
Updated: 12 hours ago
Updated: 12 hours ago
Name
Proportion
Langar Global HealthTech ETF
16.41%
iShares U.S. Medical Devices ETF
15.49%
Global X Robotics & Artificial Intelligence ETF
7.73%
First Trust Nasdaq Lux Digi Health Solutions ETF
7.37%
Invesco AI and Next Gen Software ETF
5.9%
Goldman Sachs Future Health Care Equity ETF
5.44%
Franklin Intelligent Machines ETF
5.22%
Neuberger Berman Disrupters ETF
5.01%
ProShares Nasdaq-100 Dorsey Wright Momentum ETF
4.4%
Fidelity Digital Health ETF
4.27%
View more
Langar Global HealthTech ETF
Proportion16.41%
iShares U.S. Medical Devices ETF
Proportion15.49%
Global X Robotics & Artificial Intelligence ETF
Proportion7.73%
First Trust Nasdaq Lux Digi Health Solutions ETF
Proportion7.37%
Invesco AI and Next Gen Software ETF
Proportion5.9%
Goldman Sachs Future Health Care Equity ETF
Proportion5.44%
Franklin Intelligent Machines ETF
Proportion5.22%
Neuberger Berman Disrupters ETF
Proportion5.01%
ProShares Nasdaq-100 Dorsey Wright Momentum ETF
Proportion4.4%
Fidelity Digital Health ETF
Proportion4.27%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Aug 05, 2021
Split
1>3
Date
Type
Ratio
Aug 05, 2021
Split
1>3
